Preimplantation genetic testing (PGT) provides a way to test the DNA of embryos created through IVF for specific genetic diseases based on the risks that apply to a particular individual or couple.

There are three types of PGT that a doctor may recommend depending on the risks that exist for a patient or couple:

  • PGT for aneuploidy (PGT-A) is used to screen embryos for sporadic (random) chromosomal abnormalities that can lead to failed implantation after an embryo transfer, miscarriage, or the birth of a child with a chromosomal disorder, such as Down syndrome.

  • PGT for structural rearrangements (PGT-SR) is also used to test embryos for chromosomal abnormalities; however, more specifically, the goal is to identify embryos with abnormalities related to a balanced chromosomal rearrangement (such as a translocation or inversion) that is carried by one of the parents.

  • PGT for monogenic disorders (PGT-M) is used to test embryos for specific single gene disorders, such as cystic fibrosis or sickle cell anemia, when there is a known high risk for an individual or couple to have an affected child.


Want to learn more? Use the links below.


Contact US

5777 West Century Boulevard

Suite 540

Los Angeles, CA 90045


Tel: 310-737-8156


© 2019 by SEQUENCE46, LLC.

Notice of Privacy Practices